These data indicate the efficacy of a new combinatorial gene therapy aimed at rescuing DA function and related phenotype in a mouse model that best approximates DAT deficiency found in DTDS. Here, SLC6A3 is linked to SLC6A3-related dopamine transporter deficiency syndrome.